With the expiration of a contract to produce antibiotic medicines for Sandoz, GSK will shutter a 75-year-old manufacturing ...

GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of ...

British drugmaker GSK on Thursday announced positive results from its mid-stage trial of its seasonal influenza vaccine programme using the messenger RNA (mRNA) technology, saying it would now ...

Phase 2 data demonstrated positive immune responses to A and B strains, with acceptable safety and reactogenicity profile, meeting all pre-defined study endpoints Vaccine candidate based on CureVac's ...

LONDON, UK I 12, 2024 I GSK plc (LSE/NYSE: GSK) today announced positive headline results of a phase II trial (NCT06431607) for its mRNA seasonal ...

(Alliance News) - GSK PLC on Thursday hailed a "significant advancement" as it reported positive findings from a trial on a possible flu vaccine.

"GSK continues to develop and optimise its mRNA capabilities through investments and partnerships, including in AI/ML-based sequence optimisation, nanoparticle design and manufacturing," it said ...

GSK has shared positive headline results for its mRNA seasonal influenza vaccine and outlined that it will now progress the ...

GLAXOSMITHKLINE (GSK) has confirmed that its manufacturing operations will cease next year as its current contract with a ...

Pharmaceutical company Glaxo Smith Kline has been described as a long-standing 'integral part of the Ulverston community' as local people express sadness at its impending closure.

British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine ...